A detailed history of 180 Wealth Advisors, LLC transactions in Incyte Corp stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 5,036 shares of INCY stock, worth $383,390. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,036
Previous 5,036 -0.0%
Holding current value
$383,390
Previous $305,000 8.85%
% of portfolio
0.05%
Previous 0.05%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$51.18 - $63.75 $13,920 - $17,340
272 Added 5.71%
5,036 $305,000
Q1 2024

Apr 15, 2024

BUY
$56.55 - $66.59 $11,536 - $13,584
204 Added 4.47%
4,764 $271,000
Q3 2023

Oct 31, 2023

BUY
$57.77 - $65.93 $50,259 - $57,359
870 Added 23.58%
4,560 $263,000
Q2 2023

Jul 11, 2023

BUY
$60.95 - $75.51 $2,498 - $3,095
41 Added 1.12%
3,690 $229,000
Q1 2023

Apr 07, 2023

BUY
$70.23 - $86.01 $2,528 - $3,096
36 Added 1.0%
3,649 $263,000
Q4 2022

Feb 02, 2023

BUY
$67.18 - $84.11 $9,338 - $11,691
139 Added 4.0%
3,613 $290,000
Q3 2022

Oct 12, 2022

BUY
$66.18 - $82.86 $3,309 - $4,143
50 Added 1.46%
3,474 $232,000
Q2 2022

Jul 11, 2022

SELL
$66.18 - $83.18 $3,176 - $3,992
-48 Reduced 1.38%
3,424 $266,000
Q1 2022

Apr 22, 2022

BUY
$66.02 - $79.71 $6,998 - $8,449
106 Added 3.15%
3,472 $276,000
Q3 2021

Oct 28, 2021

BUY
$68.67 - $84.02 $2,472 - $3,024
36 Added 1.08%
3,366 $221,000
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $35,781 - $39,213
448 Added 15.54%
3,330 $245,000
Q1 2021

May 25, 2021

BUY
$76.02 - $100.5 $22,577 - $29,848
297 Added 11.49%
2,882 $239,000
Q4 2020

Jan 27, 2021

BUY
$80.74 - $97.7 $208,712 - $252,554
2,585 New
2,585 $243,000
Q3 2020

Oct 23, 2020

SELL
$85.07 - $109.69 $177,030 - $228,264
-2,081 Closed
0 $0
Q2 2020

Jul 21, 2020

BUY
$74.18 - $108.93 $154,368 - $226,683
2,081 New
2,081 $217,000
Q1 2018

Jun 01, 2018

SELL
$83.06 - $100.98 $338,303 - $411,291
-4,073 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$93.56 - $116.6 $381,069 - $474,911
4,073
4,073 $386,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track 180 Wealth Advisors, LLC Portfolio

Follow 180 Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 180 Wealth Advisors, LLC with notifications on news.